Search for: "Pfizer, Inc." Results 1301 - 1320 of 1,513
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jun 2008, 1:48 pm
Pfizer's legal department has had its share of changes and turmoil over the last few months.First Alan Hesketh, Pfizer Inc.'s vice president and global head of patents was charged with child pornography.A month later, Pfizer's general counsel, and Kindler-confidant, Alan Waxman, resigned for "personal reasons. [read post]
18 Jun 2008, 12:41 pm
The Lipitor Scorecard has been updated, so go and have a look at the latest results - across 23 countries.For those keen on a little pharmaceutical patent blood sport, don't despair, the battle wages on in five European counries: Finland, Spain, Portugal, Denmark and RomaniaHere's the press release from Pfizer: Pfizer and Ranbaxy Settle Lipitor Patent Litigation (mostly) Worldwide Ranbaxy to Receive License in U.S. on November 30, 2011; NEW YORK--(BUSINESS… [read post]
18 Jun 2008, 4:39 am
AP reports: Pfizer Inc. and India's Ranbaxy Laboratories Ltd. said June 18 they have settled their patent dispute over the blockbuster cholesterol drug Lipitor, delaying the release of generic versions in the U.S. until Nov. 30, 2011.Forbes gave a more complete account of the event, and noted an immediate drop in Ranbaxy stock of 5%:Under the terms of the agreement, Ranbaxy will have a license to sell generic versions of Lipitor and Caduet in the United States, as of Nov.… [read post]
11 Jun 2008, 8:11 pm
Today Pfizer Inc's stock price hits rock bottom $17.55Unbelievable. [read post]
5 Jun 2008, 6:29 pm
Kindler's secret plan for Pfizer is not to get the stock up . . . that's virtually impossible, and he knows it.Solution: Drive the stock down to below $14, enough to get the sharks circling, then accept a take-over offer for $22, and cash in all executive management parachutes.You heard it here first.By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [read post]
4 Jun 2008, 3:44 pm
Inc. and Pfizer Inc., but there is also an unintended downside. [read post]
30 May 2008, 1:39 pm
Yesterday, Pfizer fell 3 cents to $19.30 in New York Stock Exchange composite trading. [read post]
30 May 2008, 9:42 am
McKinnell who was a Bush Ranger and tried to force every employee to support the GOP.Anyway, turns out in Kindler's new Pfizer only Democrats need to apply--at least that is what his recent hiring of Sally Susman and Amy Schulman would indicate; both of them have a perfect record supporting democrats, just like their new boss.Pfizer Inc named Sally Susman Senior Vice President of Worldwide Communications and Chief Communications Officer with overall responsibility for… [read post]
30 May 2008, 9:09 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
29 May 2008, 4:25 pm
Here's an excerpt: Pfizer Inc. is preparing an advertising and public-relations campaign to counter concerns about its antismoking drug Chantix, once... [read post]
29 May 2008, 10:48 am
This is kind of funny:Anyone who does a Google search on Pfizer Inc.'s new Super Lawyer, Amy Schulman, will find . . . [read post]
28 May 2008, 4:37 am
Leaving for "personal reasons" never seems to be a good thing, but hey, who are we to judge.Instead Pfizer Inc is getting a rising star--and workaholic. [read post]
23 May 2008, 12:57 pm
Manufacturer Pfizer Inc. strongly defended Chantix. [read post]
23 May 2008, 5:38 am
" Chantix, made by Pfizer, Inc., was attacked in a study by a non-profit group on Wednesday for possible links to seizures, dizziness, heart irregularity, diabetes and more than 100 accidents. [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
8 May 2008, 12:22 pm
Pfizer Inc., 358 F.3d 659 (9th Cir. 2004). [read post]
4 May 2008, 8:42 pm
Pfizer Inc. et al. v. [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still possible under… [read post]
1 May 2008, 11:21 am
Beretta USA, Inc., No. 05-6942-cv (2d Cir. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]